Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP473135.RA-feIaqbNJtWdT2MjfnEE8A83nQHlMM78fyiCx1a-LKo130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP473135.RA-feIaqbNJtWdT2MjfnEE8A83nQHlMM78fyiCx1a-LKo130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP473135.RA-feIaqbNJtWdT2MjfnEE8A83nQHlMM78fyiCx1a-LKo130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP473135.RA-feIaqbNJtWdT2MjfnEE8A83nQHlMM78fyiCx1a-LKo130_provenance.
- NP473135.RA-feIaqbNJtWdT2MjfnEE8A83nQHlMM78fyiCx1a-LKo130_assertion description "[Our finding of wide expression of DR4/DR5 in ESFT in vivo, in combination with their high sensitivity to TRAIL in vitro and the reported lack of toxicity of TRAIL in mice and monkeys, suggests that TRAIL may be a novel effective agent in the treatment of ESFTs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP473135.RA-feIaqbNJtWdT2MjfnEE8A83nQHlMM78fyiCx1a-LKo130_provenance.
- NP473135.RA-feIaqbNJtWdT2MjfnEE8A83nQHlMM78fyiCx1a-LKo130_assertion evidence source_evidence_literature NP473135.RA-feIaqbNJtWdT2MjfnEE8A83nQHlMM78fyiCx1a-LKo130_provenance.
- NP473135.RA-feIaqbNJtWdT2MjfnEE8A83nQHlMM78fyiCx1a-LKo130_assertion SIO_000772 11289151 NP473135.RA-feIaqbNJtWdT2MjfnEE8A83nQHlMM78fyiCx1a-LKo130_provenance.
- NP473135.RA-feIaqbNJtWdT2MjfnEE8A83nQHlMM78fyiCx1a-LKo130_assertion wasDerivedFrom befree-20140225 NP473135.RA-feIaqbNJtWdT2MjfnEE8A83nQHlMM78fyiCx1a-LKo130_provenance.
- NP473135.RA-feIaqbNJtWdT2MjfnEE8A83nQHlMM78fyiCx1a-LKo130_assertion wasGeneratedBy ECO_0000203 NP473135.RA-feIaqbNJtWdT2MjfnEE8A83nQHlMM78fyiCx1a-LKo130_provenance.
- befree-20140225 importedOn "2014-02-25" NP473135.RA-feIaqbNJtWdT2MjfnEE8A83nQHlMM78fyiCx1a-LKo130_provenance.